Ruxolitinib is highly effective in steroid-resistant graft-versus-host disease: real-world data from a single center.

Pol Arch Intern Med

Department of Hematology and Bone Marrow Transplantation, Faculty of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Published: March 2023

Download full-text PDF

Source
http://dx.doi.org/10.20452/pamw.16435DOI Listing

Publication Analysis

Top Keywords

ruxolitinib highly
4
highly effective
4
effective steroid-resistant
4
steroid-resistant graft-versus-host
4
graft-versus-host disease
4
disease real-world
4
real-world data
4
data single
4
single center
4
ruxolitinib
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!